(Reuters) - Mylan NV, which has come under fire for its drug pricing, said on Friday it would start selling a generic version of its life-saving EpiPen allergy treatment for $300 per two-pack, a more ...

Viatris shared that the Antitrust Division of the U.S. Department of Justice has advised that it no longer considers Mylan, and its former president, Rajiv Malik, a subject of its antitrust ...

Sen. Patty Murray (D-WA) on Tuesday sent a letter to Mylan CEO Heather Bresch seeking more details, including e-mail communications, on the ways that Mylan attempted to keep Teva’s generic EpiPen from ...

The CAFC also affirmed the district court’s ruling that Actelion failed to prove infringement by an equivalent, according to ipwatchdog.com. The report went on to say that Actelion further argued that ...

CVS Health, which owns more than 9,600 retail pharmacies and 1,100 walk-in clinics, will offer a lower-cost generic version of the Adrenaclick epinephrine auto-injector, targeting Mylan after the ...

Mylan, which was slammed by Congress for raising the price of the EpiPen, began selling a generic and cheaper version of the drug Friday. The company said the generic EpiPen would be available for ...

Authorized Generics: Why Mylan Would Compete With Itself in the EpiPen Market As part of an attempt to quell the furor over its more than 400% price increase for its life-saving EpiPen, Mylan ...

Generic drug maker Mylan received final FDA approval for a generic version of Pfizer’s blockbuster blood-pressure medicine Norvasc. Mylan said in a statement that since it was the first generic ...

NEW YORK, March 27 (Reuters) - Mylan Laboratories Inc. appeared set to have exclusive rights to sell generic versions of Pfizer Inc.'s Norvasc blood-pressure drug until at least April 13 after a U.S.

Mylan N.V. (NASDAQ, TASE: MYL) today announced that its abbreviated new drug application (ANDA) for fluticasone propionate 100, 250, 500 mcg and salmeterol 50 mcg inhalation powder has been accepted ...